Skip to main content
. 2014 Jun 17;111(4):781–789. doi: 10.1038/bjc.2014.337

Table 1. Adjusted P-values (pVals Adj) and fold changes (FCs) of genes selected by the microarray study.

 
 
PCa vs BPH
PCa vs PCa 0%
Gene name Gene ID pVals Adj FCs pVals Adj FCs
Claudin 3
CLDN3
8.08E-05
3.08
0.459
1.23
T-cell receptor gamma alternate reading frame protein
TARP
0.00094
3.24
0.0914
1.69
Chromosome 15 open reading frame 48
C15orf48
0.00363
3.48
0.355
1.73
Alpha-methylacyl-CoA racemase
AMACR
0.0371
5.42
0.0973
10.34
Homeobox C6
HOXC6
0.0204
3.11
0.183
3.22
Interleukin 6
IL6
0.0165
4.57
0.446
0.53
LIM domain only 3 (rhombotin-like 2)
LMO3
0.00424
0.28
0.364
0.78
Chemokine (C-X-C motif) ligand 13
CXCL13
0.00753
0.20
0.945
1.05
Bone morphogenetic protein 5
BMP5
0.00810
0.22
0.818
0.92
Prostaglandin-endoperoxide synthase 1
PTGS1
0.00934
0.21
0.307
0.75
Ring finger protein 112
RNF112
0.0222
0.33
0.0670
0.73
NEL-like 2 (chicken) NELL2 0.0255 0.15 0.480 0.68

Abbreviations: BPH=benign prostatic hyperplasia; PCa=prostate cancer; PCa 0%=non-cancerous samples from cancer-bearing prostates.